This message was sent to ##Email##
|
|
|
| |
 As 2018 comes to a close, ACS would like to wish its members, partners and other industry professionals a safe and happy holiday season. As we reflect on the past year for the industry, we would like to provide the readers of The Brief a look at the 10 most accessed articles from the year. Here is Part 1. Our regular publication will resume Thursday, Jan. 3.
|
ACS
From June 21: The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has granted its year-end 2017 Outstanding Achievement Award to a select group of 16 accredited cancer programs throughout the United States. Award criteria were based on qualitative and quantitative surveys of cancer programs conducted during the second half of 2017.
READ MORE
The JAMA Network
From Jan. 11: Breast implants are among the most commonly used medical devices. Since 2008, the number of women with breast implants diagnosed with anaplastic large-cell lymphoma in the breast (breast-ALCL) has increased, and several reports have suggested an association between breast implants and risk of breast-ALCL. However, relative and absolute risks of breast-ALCL in women with implants are still unknown, precluding evidence-based counseling about implants.
READ MORE
|
Promoted by
|
|
|
|
 |
Berkeley News
From April 26: Over the course of her lifetime, a woman has a one in eight chance of developing breast cancer. The earlier the cancer is detected, the more likely bad luck can turn to good.
Now new technology being developed by UC Berkeley engineers could dramatically improve the speed and accuracy of early breast cancer detection through the use of microfluidics.
READ MORE
ABC News
From March 15: It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient's chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung.
They were hidden cancers revealed by fluorescent dye, an advance that soon may transform how hundreds of thousands of operations are done each year.
READ MORE
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
Medical Xpress
From March 29: For many years, physicians have puzzled over why people with "clean" colonoscopies went on to develop colon cancer. New findings from the Oklahoma Medical Research may help explain why, and the discovery could lead to ways to detect these cancers earlier and more effectively. Trailing only lung cancer, colon cancer is the leading cause of cancer deaths for men and women, killing 65,000 Americans each year. Still, life expectancy improves considerably if the cancer is detected early. People whose colon cancer is discovered in the earliest stage have a five-year survival rate of 90 percent, while those whose cancer is found in the latest stage have an 8 percent rate.
READ MORE
|
|
|
|
|
| |
Live Science
From Sept. 13: Many cancer cells can divide indefinitely by flicking on an "immortality switch," a trick most other cell types can't perform. Now, researchers have discovered a way to short-circuit that switch, which may slow or halt the spread of more than 50 types of cancer, including the kind of brain cancer that Sen. John McCain died from last month.
READ MORE
|
Promoted by
|
|
|
|
 |
TIME
From April 26: After Keith Beck died of bile duct cancer last year, family members said, more than 900 people showed up to pay respects to the popular athletic director at the University of Findlay in northwestern Ohio.
Many were former students who recalled acts of kindness during Beck’s nearly 30-year career: $20 given to a kid who was broke, textbooks bought for a student whose parents were going through bankruptcy, a spot cleared to sleep on Beck’s living room floor. But few knew about Beck’s final gesture of generosity. The 59-year-old had agreed to a “rapid autopsy,” a procedure conducted within hours of his death on March 28, 2017, so that scientists could learn as much as possible from the cancer that killed him.
READ MORE
The Washington Post
From Jan. 18: The Food and Drug Administration recently cleared the first treatment for patients with advanced breast cancer caused by BRCA mutations, which are genetic defects that raise the risk of malignancies.
The drug, called Lynparza, already is approved for certain patients with advanced ovarian cancer associated with the same mutations. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in a statement that expanding the approval to breast-cancer patients "demonstrates the current paradigm of developing drugs that target the underlying genetic causes of a cancer, often across cancer types."
READ MORE
 |
|
Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com
is your best option for the future.
|
|
ACS
From Feb. 8: A standardized protocol for managing patients immediately before, during and after colorectal operations not only improved clinical outcomes, it also significantly reduced overall hospital costs. One of the first studies to investigate hospital costs associated with an enhanced recovery pathway for colorectal patients was published online as an “article in press” on the Journal of the American College of Surgeons website in advance of print publication. “The enhanced recovery protocol provides clinical benefit by allowing surgical patients to recover quicker, use less narcotic medication and have a smoother recovery that gets them out of the hospital and hopefully back to work sooner. This study shows there is financial benefit from using the standardized pathway as well,” said study author Ian Paquette, MD, FACS, an associate professor of surgery at the University of Cincinnati College of Medicine.
READ MORE
Forbes
From May 10: Zika, polio and adenovirus are hardly the first trio that comes to mind when considering the "next big thing" in cancer therapy. Polio alone killed more than 3,000 Americans per year in the 1950s before vaccination programs, and it continues to ravage the developing world. Babies with severe brain deformities due to Zika are still being born in South America.
Despite this, these killer viruses may well be a surprising source of hope for those with currently incurable cancers.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
